• SNP single-nucleotide polymorphism • qPCR quantitative real-time polymerase chain reaction • a6A N6-allyladenosine • RT reverse transcriptase • CyTOF mass cytometry by time-of-flight • Pre-DC dendritic cells precursors
Purpose and Rationale
Diagnostics is the core of biomedical research and clinical practice, which guides the prevention and treatment of diseases for better healthcare globally. [1] [2] [3] Notably, precision diagnostics relies on omic analysis to overcome the limitation in accuracy by an individual biomarker, [4] [5] [6] [7] due to the complex nature of physiological and pathological process. 1, 8, 9 Among numerous analytical approaches for omics, mass spectrometry (MS) has become the major tool due to the desirable throughput, sensitivity, and identification capability. [10] [11] [12] [13] To date, the state-of-art MS methods and techniques have advanced omics in all levels including genomics, 14, 15 proteomics, [16] [17] [18] and metabolomics. [19] [20] [21] * Corresponding Authors: E-mail: jjwan@chem.ecnu.edu.cn, k.qian@sjtu.edu.cn Nowadays, interdisciplinary research is fundamental to achieve real case applications of MS in clinics. Particularly, development of nanotechnology enhanced sample treatment and detection efficiency of MS for diagnostics.
10, [22] [23] [24] For sample treatment, nanoscale materials and devices afford unique size-dependent properties for selective extraction of either a specific molecule or a group of molecules. 3, 20, 25, 26 For detection efficiency, nanoscale materials and devices contribute to the amplified ionization performance with orders of magnitude. 24, 25, 27 Therefore, nanotechnology can tackle the key obstacles for MS-based omics, which can be further combined with instrumentation and data mining for next generation of precision diagnostics.
Herein, we foresee a coming era of precision diagnostics based on nano-assisted MS. We show a few important developments in the field (Scheme 1 and [31] quantitative real-time PCR [33] sanger gene sequencing [34] sensitivity: high throughput: low cost: very high quantitation: yes Nano-MS based proteomics sensitivity: high throughput: high cost: moderate quantitation: yes chromatography [38] protein microarrays [39] gel electrophoresis [40] sensitivity: high throughput: moderate cost: high quantitation: yes Nano-MS based metabolomics sensitivity: very high throughput: very high cost: low quantitation: yes biochemical analyzer [47] NMR [48] electrochemical sensing [49] sensitivity: high throughput: low cost: moderate quantitation: yes MS = mass spectrometry; PCR = polymerase chain reaction.
Summary of relevant literature and discussion

Detection of nucleic acids for genetic analysis
Genomics is the study of nucleic acids for genetic evaluation of an organism, analyzing the structure and function of genomes. 28, 29 Compared to the well-defined analysis of mutations at DNA level, the emerging fields of RNA editing, methylation, and splicing generate a library of transcript isoforms encoding genetic information from DNA-RNA-proteins. 30 RNA editing is a molecular process effectively altering the amino acid sequence of the encoded protein to produce a new genomic sequence. It is crucial to develop "omics approach" for RNA editing, since RNA editing deals with modifying the nucleotide sequence in a specific genomic template to produce a new nucleotide sequence for understanding the molecular mechanisms of disease such as cancer. Deciphering these mutated sequences contributes to the development of disease-specific prognostic and therapeutic approaches. Different analytical methods have been employed for detailed analysis of genetic sequences such as gene chips, 31 single-nucleotide polymorphism (SNP) microarrays, 32 quantitative real-time polymerase chain reaction (qPCR), 33 sanger gene sequencing, 34 and so on. Among these, SNP microarray genotyping is a tool to determine genetic mutations, phenotypespecific panels, and genome-wide panels of a particular individual. Combining MS with these microarray techniques provides the ability for rapid, accurate, and quantitative characterization of post-transcriptionally modified nucleosides based on their molecular weight changes. Hence, the continued improvements in the methodology and instrumentation used for the mass spectral analysis of nucleic acids will increase the applications of this technology to the field of genomics.
MS-based microarrays enable hybridization free analysis of nucleic acids based on their respective molecular weights. Research groups lead by Chuan He and Jianzhao Liu reported a new small molecule called as N6-allyladenosine (a 6 A) for RNA (ribonucleic acid) labeling through both metabolic and enzyme-assisted manners (Figure 1 ). 15 The total extracted RNAs were digested into single nucleosides and analyzed by ultra-highperformance liquid chromatography coupled with triple quadrupole tandem mass spectrometer (UHPLC-QQQ-MS/MS) for accurate quantification of a 6 A levels. Notably, the increased molar mass of a modified probe by MS quantification validated the proposed RNA post-treatment reaction mechanism. Overall, the metabolically incorporated a 6 A molecule provides facile differentiation of labeled and unlabeled RNA using reverse transcriptase (RT)-induced mutation assay for its potential sequencing applications in the RNA field. The MALDI-TOF spectra of modified and unmodified standard RNA oligonucleotides revealed the feasibility of RNA modification. A conceptually distinct approach was developed based on the different chemical properties of nucleosides with 2′-OH and 2′-OMe groups by periodate oxidation for exposing, enriching and mapping Nm sites in the transcriptome with single-nucleotide precision. Thus, deciphering the deregulated RNA processing events facilitates the detection of rare but functionally relevant transcripts at cellular level. The RNA editing studies will provide key insights for detecting disease-specific biomarkers and development of novel therapeutic strategies.
Detection of proteins/peptides for proteomic analysis
Proteomics focuses on the large-scale study of proteins produced or modified at the gene or cellular level by an organism. Proteomics is more complicated owing to the distinct gene expressions in every system. 6, 35, 36 MS-based proteomics is an advanced technology interpreting encoded information in the genomes. 35 ,42, 43 The approach has been successful in the case of small sets of proteins isolated in specific functional contexts. 44 Detecting patterns of a differentially expressed proteins clinical samples shows the potential to diagnose the presence and stage of many diseases such as cancer. 35, 45 Thus, the ability of MS to precisely identify and quantify thousands of proteins from complex samples has broadly impacted biology and medicine.
Hu and co-workers have developed a method using antibody-labeled and energy-focusing porous discoidal silicon nanoparticles (nanodisks) for detection of specific peptide fragments present in Mycobacterium tuberculosis (Mtb) using a high-throughput MS approach (Figure 3) . 16 They unraveled the complexity of the human DC lineage at the single-cell level, revealing a continuous process of differentiation that starts in the bone marrow, and diverges at the point of emergence of pre-DC and plasmacytoid DC(pDC) potentials culminating in maturation of both lineages in the blood. Thus, the phenotypic heterogeneity in the circulating mature DC population can be evaluated by single-cell RNA sequence analysis, which was further confirmed by the marked dispersion in the t-stochastic neighbor embedding (tSNE) analysis of the CyTOF data. Even though MSbased proteomics is still an emerging technology, analysis of non-fragmented proteins with high accuracy has the potential to provide insights into detailed structural analysis.
Figure 3. Mass spectrometry detection of proteins/peptides for proteomic analysis. The NanoDisk-MS platform. (i) Recognition and enrichment of target peptides and stable isotope-labeled internal standard peptides by antibody-conjugated nanodisks. (ii) Enhanced MS signals allowing quantification of target peptide at low concentrations. Reproduced with permission.[16] Copyright 2017, Proceedings of the National Academy of Sciences of the United States of America (PNAS) group.
NanoDisk-MS diagnosed active
Detection of small molecules for metabolomics analysis
The youngest emerging omics member, "metabolomics" has been considered important in early disease diagnosis and clinical evaluation. 7, 46 Analyzing the levels of all cellular metabolites from biological samples demonstrates the pathological and physiological status in biochemical pathway for biomarker identification. Identification of this distinctive fingerprinted metabolic pattern of an individual from the biological fluids could provide new insights for precision diagnostics. Compared to traditional biochemical analyzer, 47 nuclear magnetic resonance spectrometry (NMR), 48 and electrochemical methods 49 for metabolite analysis, MS techniques edge the unique advantages of desirable scanning speed, resolution, selectivity, sensitivity, and simple instrument structure over other methods in large-scale clinical applications. 11, 22 Notably, the use of matrices is of key significance in MS for laser energy transfer and desorption/ionization of analytes.
Qian research group developed a designer silver nanoshell (SiO2@Ag) matrix for LDI MS assisted detection of small metabolites in cerebrospinal fluid (CSF) of patients with postoperative brain infection ( Figure 6 ). Isotopic quantification of selected metabolites revealed patients with postoperative brain infection by cerebrospinal fluid (CSF) analysis and monitored the drug concentrations in both CSF and serum to investigate the bloodbrain/CSF-barriers and for pharmacokinetics study. The same group also developed a novel plasmonic chip with gold nanoshells on the surface for in vitro metabolic diagnosis of early-stage lung cancer patients using serum and exosomes (Figure 7 ). [21] Copyright 2017, American Association for the Advancement of Science.
The MasSpec Pen was utilized for molecular analysis of potential cancer biomarkers of normal and cancerous tissue samples from 253 patients. Statistical analysis technique allowed prediction of cancer with high sensitivity (96.4%), specificity (96.2%), and overall accuracy (96.3%). Thus, MS-based highperformance metabolic analysis towards precision medicine, initiates the development of advanced diagnostic tools identifying various metabolic biomarkers.
Conclusion
In this review, we summarized the key milestones of MS, to address the needs from clinical omics towards precision diagnostics. In near future, research lines in the field would include but would not be limited to (1) integrated MS systems with low costs and smaller sizes; (2) high analytical performance for multi-omic analysis in one specimen; and (3) precision diagnosis of major diseases in large populations. Notably, considering the commercial value and social benefit of precision diagnostics, there would be emerging high-tech companies around the world to mine nano-assisted MS and facilitate the university application.
